Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference

Rhea-AI Summary

Kodiak Sciences (NASDAQ: KOD), a biopharmaceutical company focused on developing treatments for retinal diseases, announced that CEO Victor Perlroth will present at the 2025 Jefferies Global Healthcare Conference. The presentation is scheduled for June 5, 2025, at 9:20am ET in New York City. Investors can access a live webcast of the presentation through Kodiak's investor relations website at ir.kodiak.com, where it will remain available for replay for a limited time after the event.

News Market Reaction

-4.76%

1 alert

-4.76% News Effect

On the day this news was published, KOD declined 4.76%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PALO ALTO, Calif., May 29, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that Victor Perlroth, M.D., Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City, NY on Thursday, June 5, 2025, at 9:20am ET (6:20am PT).

A live webcast of the presentation will be available on the "Events and Presentations" section of Kodiak's website at http://ir.kodiak.com/ and will remain available for replay for a limited time following the event.

About Kodiak Sciences Inc. 

Kodiak Sciences (Nasdaq: KOD) is a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platform^® uses molecular engineering to merge the fields of protein-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's maturing pipeline includes three late-phase clinical assets, all three targeting Phase 3 topline data in 2026.

For more information, please visit www.kodiak.com. 

Kodiak^®, Kodiak Sciences^®, ABC^®, ABC Platform^®, ABCD™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

View original content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-2025-jefferies-global-healthcare-conference-302469141.html

SOURCE Kodiak Sciences Inc.

FAQ

When is Kodiak Sciences (KOD) presenting at the 2025 Jefferies Healthcare Conference?

Kodiak Sciences will present on Thursday, June 5, 2025, at 9:20am ET (6:20am PT) in New York City.

Who will represent Kodiak Sciences (KOD) at the Jefferies Healthcare Conference 2025?

Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences, will present at the conference.

How can investors watch Kodiak Sciences' (KOD) presentation at the Jefferies conference?

Investors can watch the live webcast through the 'Events and Presentations' section of Kodiak's website at ir.kodiak.com.

What is Kodiak Sciences' (KOD) main business focus?

Kodiak Sciences is a biopharmaceutical company focused on researching, developing and commercializing therapeutics for retinal diseases.